Reed Elsevier Ventures

Reed Elsevier Ventures was the corporate venture capital arm of Reed Elsevier, the global information and analytics provider now known as RELX. Established in 2000, the firm specialized in early-to-late-stage investments in high-growth companies within the technology, media, and healthcare information sectors. Its investment strategy focused on businesses that leveraged data and analytics to provide clinical decision support and health information services. Notable portfolio companies included Healthline, HealthDirect, and various other digital health platforms. While the firm is no longer actively investing under the Reed Elsevier Ventures name following the 2015 corporate rebranding, it played a significant role in shaping the digital health information landscape.